Pharmaceutical Technology Europe spoke with Piero Iamartino, R&D director at Micro-Macinazione, about the role of micronization in pharmaceutical manufacturing. Poor bioavailability is often a result ...
The CDMO is investing £6 million into a new facility at its United Kingdom site to expand its milling, micronization, and solid form capabilities. Contract development and manufacturing organization ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results